Efficacy and Safety of Phentermine/Topiramate in Youth and Young Adults with Hypothalamic Obesity

What is the goal of the study?

The purpose of this study is to evaluate how safe and effective the drug Qsymia (Phentermine/Topiramate or Ph/T) is for children, adolescents, and young adults with hypothalamic obesity. We will also evaluate if Ph/T helps with weight loss and changes in hunger in patients with hypothalamic obesity. Qsymia is FDA approved to treat adults with obesity (BMI of 30 kg/m2 or greater) and pediatric patients, aged 12 and older, with obesity (BMI in 95th %ile or greater).

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

• PI (Study Doctor): Christian Roth
• Study Team Member: ECR Endocrine Research, [email protected]